SHV-27, a novel cefotaxime-hydrolysing beta-lactamase, identified in Klebsiella pneumoniae isolates from a Brazilian hospital

J Antimicrob Chemother. 2001 Apr;47(4):463-5. doi: 10.1093/jac/47.4.463.

Abstract

From a collection of cefotaxime-resistant Klebsiella pneumoniae isolated from neonatal blood culture specimens in a maternity hospital in Aracaju, Brazil, two isolates (strains KPBRZ-842 and -843, indistinguishable by pulsed-field gel electrophoresis) were found to produce beta-lactamases with isoelectric points (pI) of 5.4 and 8.2, respectively. Using a gel overlay method, cefotaxime hydrolysis was shown to be associated with the pI 8.2 protein. Nucleotide sequencing of the gene encoding the pI 8.2 beta-lactamase revealed a bla(SHV-ESBL)-type gene differing from the gene encoding SHV-1 by three silent point mutations, and a fourth that resulted in an amino acid substitution, aspartate for glycine, at position 156. This novel SHV-type extended-spectrum beta-lactamase is designated SHV-27.

MeSH terms

  • Anti-Bacterial Agents / metabolism*
  • Anti-Bacterial Agents / pharmacology
  • Aztreonam / pharmacology
  • Brazil
  • Cefotaxime / metabolism*
  • Cefotaxime / pharmacology
  • Ceftazidime / pharmacology
  • DNA Mutational Analysis
  • Drug Resistance, Microbial / genetics*
  • Electrophoresis, Gel, Pulsed-Field
  • Hospitals
  • Humans
  • Klebsiella pneumoniae / drug effects
  • Klebsiella pneumoniae / enzymology*
  • Klebsiella pneumoniae / genetics
  • Klebsiella pneumoniae / isolation & purification
  • Microbial Sensitivity Tests
  • Molecular Sequence Data
  • Point Mutation / genetics
  • Polymorphism, Restriction Fragment Length
  • beta-Lactamases / isolation & purification
  • beta-Lactamases / metabolism*

Substances

  • Anti-Bacterial Agents
  • Ceftazidime
  • beta-lactamase SHV-27
  • beta-Lactamases
  • Aztreonam
  • Cefotaxime

Associated data

  • GENBANK/AF293345